会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid
    • 制备2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的方法
    • US08759030B2
    • 2014-06-24
    • US10523920
    • 2003-07-07
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • C12P19/44
    • C12P19/60
    • The object of the present invention is to provide a method and a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid where 5-O-α-glucopyranosyl-L-ascorbic acid and 6-O-α-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid comprising the steps of allowing α-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an α-glucosyl saccharide to form 2-O-α-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-α-glucopyranosyl-L-ascorbic acid.
    • 本发明的目的是提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法和方法,其中5-O-α-吡喃葡萄糖基-L-抗坏血酸和6-O-α-吡喃葡萄糖基 - L-抗坏血酸不是以这样的少量形成或形成,也可以不形成。 本发明通过提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法来解决上述目的,其包括以下步骤:将α-异麦芽糖基葡萄糖形成酶与或不与环糊精葡聚糖转移酶(EC 2.4.1.19)一起 作用于包含L-抗坏血酸和α-葡萄糖基糖的溶液中以形成2-O-α-吡喃葡萄糖基-L-抗坏血酸并收集形成的2-O-α-吡喃葡萄糖基-L-抗坏血酸。
    • 5. 发明授权
    • Cyclic maltosylmatose
    • 循环麦芽糖
    • US07309697B2
    • 2007-12-18
    • US10569959
    • 2004-08-26
    • Kazuhisa MukaiHikaru WatanabeTomoyuki NishimotoMichio KubotaShigeharu FukudaToshio Miyake
    • Kazuhisa MukaiHikaru WatanabeTomoyuki NishimotoMichio KubotaShigeharu FukudaToshio Miyake
    • A61K31/715C07H1/00
    • A61K9/2018A21D2/181A23L2/52A23L2/60A23L13/428A23L27/33A23L33/10A61K8/60A61Q11/00C07H3/06C12N9/1048C12P19/18
    • An object of the present invention is to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme forming the non-reducing saccharide, a method and process for producing the same, a DNA encoding the enzyme, a recombinant DNA and transformant comprising the DNA, a composition comprising the non-reducing saccharide, and uses thereof. The present invention solves the above object by providing a novel cyclic saccharide having a structure of cyclo{→6)-α-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→6)-α-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→6}, cyclic maltosylmaltose, novel cyclic maltosylmaltose-forming enzyme, a method and process for producing the same, a DNA encoding the enzyme, a recombinant DNA and transformant comprising the DNA, a composition comprising the cyclic maltosylmaltose or a saccharide composition comprising the same, and uses thereof.
    • 本发明的目的是通过提供一种由葡萄糖组成的新型非还原性糖组成并提供形成非还原性糖的新型酶,提供一种非还原性糖的方法及其制备方法 ,编码该酶的DNA,重组DNA和包含该DNA的转化体,包含非还原性糖的组合物及其用途。 本发明通过提供具有环{ - > 6)-α-D-吡喃葡萄糖基 - (1-> 4)-α-D-吡喃葡萄糖基 - (1-> 6) - 结构的新型环状糖来解决上述目的。 α-D-吡喃葡萄糖基 - (1-> 4)-α-D-吡喃葡萄糖基 - (1-> 6),环状麦芽糖基麦芽糖,新型环状麦芽糖基麦芽糖酶形成酶,其制备方法和方法,编码酶 ,重组DNA和包含该DNA的转化体,包含环状麦芽糖基麦芽糖的组合物或包含其的糖组合物及其用途。
    • 6. 发明申请
    • Process for producing 2-0-alpha-d-glucopyranosyl-l-ascorbic acid
    • 制备2-0-α-d-吡喃葡萄糖基-1-抗坏血酸的方法
    • US20060216792A1
    • 2006-09-28
    • US10523920
    • 2003-07-07
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • Kazuhisa MukaiKeiji TsusakiMichio KubotaShigeharu FukudaToshio Miyake
    • C12P19/44
    • C12P19/60
    • The object of the present invention is to provide a method and a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid where 5-O-α-glucopyranosyl-L-ascorbic acid and 6-O-α-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-α-glucopyranosyl-L-ascorbic acid comprising the steps of allowing α-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an α-glucosyl saccharide to form 2-O-α-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-α-glucopyranosyl-L-ascorbic acid.
    • 本发明的目的是提供一种生产2-O-α-glucopyranosyl-L-抗坏血酸的方法和方法,其中5-O-α-吡喃葡萄糖基-L-抗坏血酸和6-O-α-吡喃葡萄糖基-L- L-抗坏血酸不是以这样的少量形成或形成,也可以不形成。 本发明通过提供一种生产2-O-α-吡喃葡萄糖基-L-抗坏血酸的方法来解决上述目的,其包括以下步骤:将α-异麦芽糖基糖糖形成酶与或不与环糊精葡聚糖转移酶(EC 2.4.1.19)一起使用 作用于包含L-抗坏血酸和α-葡糖基糖的溶液以形成2-O-α-吡喃葡萄糖基-L-抗坏血酸并收集形成的2-O-α-吡喃葡萄糖基-L-抗坏血酸。